Treatment of multiple myeloma at specialized clinic tied to improved survival

Patients with newly diagnosed multiple myeloma (NDMM) treated at a specialized clinic have improved outcomes, with median overall survival (OS) of 152 months, according to a research letter published in the November issue of Haematologica.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup